Influenza vaccine: a travelers’ vaccine?

Authors: Marti, Franziska; Steffen, Robert; Mutsch, Margot

Source: Expert Review of Vaccines, 1 July 2008, vol. 7, no. 5, pp. 679-687(9)


Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.


Seasonal influenza affects 5–15% of the world’s population annually and is considered to be the second most frequent vaccine-preventable infection in travelers. Despite increasing travel volume worldwide, guidelines on influenza vaccination for international travel are scarce. On the basis of some national recommendations, influenza vaccine should be used based on host criteria to usual risk groups, such as old (>50–65 years) or young (6–23 months) age and those with comorbidities. Additionally, environmental and behavioral factors must be considered. Close contact with high transmission has been documented in cruise ships and during mass gatherings. Travelers crossing to the opposite hemisphere in influenza-peak season may need protection. Those visiting the tropics are at moderate risk of infection and illness during the entire year. A summary on existing traveler recommendations relating to avian influenza is included.

Keywords: influenza; pandemic influenza; travel; vaccine

Document Type: Research Article


Affiliations: University of Zurich, Institute of Social and Preventive Medicine, Division of Epidemiology and Prevention of Communicable Diseases, WHO Collaborating Centre for Traveller’s Health, Zurich, Switzerland

Publication date: July 1, 2008

Related content


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page